{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "120.00",
    "chg": 3.55,
    "chgp": "3.05%",
    "dir": 1,
    "prev_price": "116.45",
    "mcapval": "1,264.44 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE416D01022",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:29 AM",
    "bse_nse_vol": "1.46 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Faces Technical Recalibration Amid Mixed Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-stock-downgraded-to-sell-amid-technical-trend-shift-1619705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/BlissGVSPharma_mojoScore_815192.png",
        "date": "2025-03-27 08:03:54",
        "description": "Bliss GVS Pharma has recently experienced a change in its evaluation, reflecting shifts in technical trends. While the stock has shown a 9.21% return over the past year, recent financial performance has faced challenges. The company's low debt-to-equity ratio and fair valuation relative to peers indicate a cautious financial structure."
      },
      {
        "title": "Bliss GVS Pharma Experiences Mixed Technical Signals Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-price-decline-1619679",
        "imagepath": "",
        "date": "2025-03-27 08:02:33",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 121.00, down from a previous close of 124.30, with a 52-week high of 184.95 and a low of 92.25. Today's trading saw a high of 126.40 and a low of 120.55.\n\nThe technical summary indicates mixed signals across various indicators. The MACD shows a bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) presents no clear signals for both weekly and monthly assessments. Bollinger Bands and KST are bearish on a weekly basis, with KST showing a mildly bearish trend monthly. Moving averages indicate a mildly bullish stance daily, while On-Balance Volume (OBV) reflects a mildly bullish trend monthly.\n\nIn terms of performance, Bliss GVS Pharma's stock return over the past week stan..."
      },
      {
        "title": "Bliss GVS Pharma Shows Shift to Mildly Bullish Trend Amid Stable Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-receives-hold-rating-upgrade-amid-mixed-stock-performance-1572924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/BlissGVSPharma_mojoScore_770844.png",
        "date": "2025-03-24 08:02:33",
        "description": "Bliss GVS Pharma has recently experienced a change in its technical outlook, shifting to a mildly bullish trend. The company maintains a low Debt to Equity ratio and an attractive Price to Book Value ratio. Despite recent challenges, it has consistently outperformed the BSE 500 index over the past three years."
      },
      {
        "title": "Bliss GVS Pharma Shows Mixed Technical Trends Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-1572968",
        "imagepath": "",
        "date": "2025-03-24 08:01:42",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 122.50, showing a slight increase from the previous close of 121.00. Over the past week, Bliss GVS Pharma has demonstrated a notable performance, with a return of 7.36%, outperforming the Sensex, which recorded a return of 4.17% in the same period.\n\nIn terms of technical indicators, the company shows a mixed picture. The MACD indicates a bullish trend on a monthly basis, while the weekly outlook remains bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Moving averages suggest a mildly bullish sentiment on a daily basis, contrasting with the weekly and monthly indicators that lean towards a bearish stance.\n\nWhen examining the company's returns over variou..."
      },
      {
        "title": "Bliss GVS Pharma's Technical Indicators Reflect Mixed Signals Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-1451119",
        "imagepath": "",
        "date": "2025-03-19 08:03:07",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 117.70, showing a notable change from the previous close of 112.00. Over the past year, Bliss GVS Pharma has experienced a stock return of 7.64%, outperforming the Sensex, which recorded a return of 3.51% in the same period.\n\nIn terms of technical indicators, the MACD shows a mixed outlook with a bearish signal on the weekly chart and a bullish signal on the monthly chart. The Relative Strength Index (RSI) indicates no clear signal on both weekly and monthly bases. Bollinger Bands reflect a mildly bearish trend weekly and a bearish trend monthly, while moving averages suggest a mildly bullish stance on a daily basis.\n\nThe company's performance over various time frames reveals a challenging year-to-date return of -28..."
      },
      {
        "title": "Bliss GVS Pharma Faces Mixed Technical Trends Amid Recent Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-decline-15-1371800",
        "imagepath": "",
        "date": "2025-03-13 08:01:34",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 117.30, slightly down from the previous close of 117.90. Over the past year, Bliss GVS Pharma has shown a return of 7.71%, outperforming the Sensex, which recorded a return of 0.49%. However, the stock has faced challenges in the shorter term, with a year-to-date return of -28.76%, compared to the Sensex's -5.26%.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Bollinger Bands and KST both reflect bearish tendencies on a weekly basis, suggesting some caution in the market. Additionally, the moving averages indicate a mildly bullish stance on a daily basis, providing a nuanced view of the..."
      },
      {
        "title": "Bliss GVS Pharma Faces Mixed Technical Trends Amid Recent Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-decline-1346949",
        "imagepath": "",
        "date": "2025-03-13 08:01:34",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 117.30, slightly down from the previous close of 117.90. Over the past year, Bliss GVS Pharma has shown a return of 7.71%, outperforming the Sensex, which recorded a return of 0.49%. However, the stock has faced challenges in the shorter term, with a year-to-date return of -28.76%, compared to the Sensex's -5.26%.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Bollinger Bands and KST both reflect bearish tendencies on a weekly basis, suggesting some caution in the market. Additionally, the moving averages indicate a mildly bullish stance on a daily basis, providing a nuanced view of the..."
      },
      {
        "title": "Bliss GVS Pharma Experiences Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-2-1259846",
        "imagepath": "",
        "date": "2025-03-10 08:01:21",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 124.50, down from a previous close of 127.40, with a 52-week high of 184.95 and a low of 92.25. Today's trading saw a high of 129.15 and a low of 124.50.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Relative Strength Index (RSI) presents no signals for both weekly and monthly periods. Bollinger Bands indicate a bearish stance weekly, contrasting with a mildly bullish outlook monthly. Moving averages suggest a mildly bullish trend on a daily basis, while the KST and Dow Theory reflect a mildly bearish sentiment on a weekly and monthly basis.\n\nIn terms of returns, Bliss GVS Pha..."
      },
      {
        "title": "Bliss GVS Pharma Shows Divergent Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharmas-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-price-increase-1229731",
        "imagepath": "",
        "date": "2025-03-07 08:02:37",
        "description": "Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 127.40, showing a slight increase from the previous close of 124.25. Over the past year, Bliss GVS Pharma has demonstrated a return of 9.59%, outperforming the Sensex, which recorded a modest gain of 0.34%.\n\nIn terms of technical indicators, the company exhibits a mixed performance. The MACD shows a mildly bearish trend on a weekly basis, while the monthly outlook is bullish. The Bollinger Bands also reflect a similar divergence, indicating a mildly bearish stance weekly and bullish monthly. Moving averages suggest a mildly bullish trend on a daily basis, contrasting with the weekly and monthly KST and Dow Theory indicators, which remain mildly bearish.\n\nWhen comparing the stock's performance to the Sensex over va..."
      }
    ],
    "total": 68,
    "sid": "730684",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Please find attached herewith a certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities Exchange Board of India (Depositories & Participants) Regulations 2018 for the quarter ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "27-Mar-2025",
      "details": "Enclosed herewith please find attached the intimation regarding the resignation of Mr. Vilas Patil General Manager - Human Resource and a Senior Management Personnel of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Please find enclosed herewith the intimation regarding closure of Trading Window.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 18 Jul 24",
          "dt": "2024-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bliss GVS Pharma Faces Technical Recalibration Amid Mixed Financial Performance

2025-03-27 08:03:54

Bliss GVS Pharma has recently experienced a change in its evaluation, reflecting shifts in technical trends. While the stock has shown a 9.21% return over the past year, recent financial performance has faced challenges. The company's low debt-to-equity ratio and fair valuation relative to peers indicate a cautious financial structure.

Read More

Bliss GVS Pharma Experiences Mixed Technical Signals Amid Market Evaluation Revision

2025-03-27 08:02:33

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 121.00, down from a previous close of 124.30, with a 52-week high of 184.95 and a low of 92.25. Today's trading saw a high of 126.40 and a low of 120.55. The technical summary indicates mixed signals across various indicators. The MACD shows a bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) presents no clear signals for both weekly and monthly assessments. Bollinger Bands and KST are bearish on a weekly basis, with KST showing a mildly bearish trend monthly. Moving averages indicate a mildly bullish stance daily, while On-Balance Volume (OBV) reflects a mildly bullish trend monthly. In terms of performance, Bliss GVS Pharma's stock return over the past week stan...

Read More

Bliss GVS Pharma Shows Shift to Mildly Bullish Trend Amid Stable Financial Metrics

2025-03-24 08:02:33

Bliss GVS Pharma has recently experienced a change in its technical outlook, shifting to a mildly bullish trend. The company maintains a low Debt to Equity ratio and an attractive Price to Book Value ratio. Despite recent challenges, it has consistently outperformed the BSE 500 index over the past three years.

Read More

Bliss GVS Pharma Shows Mixed Technical Trends Amid Market Dynamics

2025-03-24 08:01:42

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 122.50, showing a slight increase from the previous close of 121.00. Over the past week, Bliss GVS Pharma has demonstrated a notable performance, with a return of 7.36%, outperforming the Sensex, which recorded a return of 4.17% in the same period. In terms of technical indicators, the company shows a mixed picture. The MACD indicates a bullish trend on a monthly basis, while the weekly outlook remains bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Moving averages suggest a mildly bullish sentiment on a daily basis, contrasting with the weekly and monthly indicators that lean towards a bearish stance. When examining the company's returns over variou...

Read More

Bliss GVS Pharma's Technical Indicators Reflect Mixed Signals Amid Market Dynamics

2025-03-19 08:03:07

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 117.70, showing a notable change from the previous close of 112.00. Over the past year, Bliss GVS Pharma has experienced a stock return of 7.64%, outperforming the Sensex, which recorded a return of 3.51% in the same period. In terms of technical indicators, the MACD shows a mixed outlook with a bearish signal on the weekly chart and a bullish signal on the monthly chart. The Relative Strength Index (RSI) indicates no clear signal on both weekly and monthly bases. Bollinger Bands reflect a mildly bearish trend weekly and a bearish trend monthly, while moving averages suggest a mildly bullish stance on a daily basis. The company's performance over various time frames reveals a challenging year-to-date return of -28...

Read More

Bliss GVS Pharma Faces Mixed Technical Trends Amid Recent Market Volatility

2025-03-13 08:01:34

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 117.30, slightly down from the previous close of 117.90. Over the past year, Bliss GVS Pharma has shown a return of 7.71%, outperforming the Sensex, which recorded a return of 0.49%. However, the stock has faced challenges in the shorter term, with a year-to-date return of -28.76%, compared to the Sensex's -5.26%. The technical summary indicates a mixed performance across various indicators. The MACD shows a bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Bollinger Bands and KST both reflect bearish tendencies on a weekly basis, suggesting some caution in the market. Additionally, the moving averages indicate a mildly bullish stance on a daily basis, providing a nuanced view of the...

Read More

Bliss GVS Pharma Faces Mixed Technical Trends Amid Recent Market Volatility

2025-03-13 08:01:34

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 117.30, slightly down from the previous close of 117.90. Over the past year, Bliss GVS Pharma has shown a return of 7.71%, outperforming the Sensex, which recorded a return of 0.49%. However, the stock has faced challenges in the shorter term, with a year-to-date return of -28.76%, compared to the Sensex's -5.26%. The technical summary indicates a mixed performance across various indicators. The MACD shows a bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Bollinger Bands and KST both reflect bearish tendencies on a weekly basis, suggesting some caution in the market. Additionally, the moving averages indicate a mildly bullish stance on a daily basis, providing a nuanced view of the...

Read More

Bliss GVS Pharma Experiences Mixed Technical Trends Amid Market Evaluation Revision

2025-03-10 08:01:21

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 124.50, down from a previous close of 127.40, with a 52-week high of 184.95 and a low of 92.25. Today's trading saw a high of 129.15 and a low of 124.50. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Relative Strength Index (RSI) presents no signals for both weekly and monthly periods. Bollinger Bands indicate a bearish stance weekly, contrasting with a mildly bullish outlook monthly. Moving averages suggest a mildly bullish trend on a daily basis, while the KST and Dow Theory reflect a mildly bearish sentiment on a weekly and monthly basis. In terms of returns, Bliss GVS Pha...

Read More

Bliss GVS Pharma Shows Divergent Technical Trends Amid Market Evaluation Revision

2025-03-07 08:02:37

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 127.40, showing a slight increase from the previous close of 124.25. Over the past year, Bliss GVS Pharma has demonstrated a return of 9.59%, outperforming the Sensex, which recorded a modest gain of 0.34%. In terms of technical indicators, the company exhibits a mixed performance. The MACD shows a mildly bearish trend on a weekly basis, while the monthly outlook is bullish. The Bollinger Bands also reflect a similar divergence, indicating a mildly bearish stance weekly and bullish monthly. Moving averages suggest a mildly bullish trend on a daily basis, contrasting with the weekly and monthly KST and Dow Theory indicators, which remain mildly bearish. When comparing the stock's performance to the Sensex over va...

Read More

View All News